Table 1 Comparison of the clinical characteristics of the subjects at baseline
Characteristic | Group (total = 52) | ||
|---|---|---|---|
Control (n = 25) | FRVE (n = 27) | p | |
Sex, no. (%) of participant | 0.893 | ||
 Men | 5 (20.0) | 5 (18.5) |  |
 Women | 20 (80.0) | 22 (81.5) |  |
Age (years) | 33.24 (±3.06) | 33.07 (±2.92) | 0.969 |
Height (cm) | 162.55 (±1.58) | 163.37 (±1.19) | 0.679 |
Weight (kg) | 59.36 (±2.66) | 63.69 (±2.06) | 0.201 |
Waist (cm) | 74.61 (±2.36) | 79.87 (±2.35) | 0.121 |
Hip (cm) | 94.66 (±1.62) | 95.67 (±1.46) | 0.641 |
SBP (mmHg) | 111.48 (±2.82) | 111.93 (±2.45) | 0.905 |
DBP (mmHg) | 68.40 (±2.20) | 69.96 (±2.08) | 0.608 |
Blood parameters | |||
 Glucose (mg/dL) | 92.64 (±2.32) | 89.78 (±1.67) | 0.337 |
 Insulin (uU/mL) | 10.99 (±2.89) | 16.44 (±3.32) | 0.074 |
 Albumin (g/dL) | 4.94 (±0.06) | 4.94 (±0.04) | 0.964 |
 WBC (mm3) | 6.31 (±0.30) | 6.37 (±0.25) | 0.885 |
 RBC (mm3) | 4.60 (±0.09) | 4.46 (±0.07) | 0.205 |
 Hb (g/dL) | 13.82 (±0.25) | 13.67 (±0.22) | 0.657 |
 HCT (%) | 41.09 (±0.62) | 40.59 (±0.57) | 0.555 |
 PLT (103/uL) | 258.36 (±11.88) | 235.67 (±11.64) | 0.179 |
 AST (IU/L) | 20.48 (±1.44) | 20.15 (±1.12) | 0.995 |
 ALT (IU/L) | 17.67 (±2.71) | 16.63 (±1.62) | 0.949 |
 AST/ALT ratio | 1.44 (±0.10) | 1.40 (±0.09) | 0.765 |
 GGT (mg/dL) | 18.32 (±2.02) | 21.59 (±3.06) | 0.384 |
 ALP (IU/L) | 64.56 (±2.92) | 66.00 (±4.21) | 0.783 |
 TC (mg/dL) | 190.84 (±5.08) | 179.44 (±5.69) | 0.144 |
 TG (mg/dL) | 125.76 (±23.55) | 138.74 (±22.23) | 0.589 |
 HDL-C (mg/dL) | 60.44 (±2.93) | 62.59 (±3.48) | 0.641 |
 LDL-C (mg/dL) | 105.25 (±5.39) | 92.26 (±5.61) | 0.102 |
 MDA (pmol/mL) | 321.30 (±70.57) | 225.69 (±40.30) | 0.373 |
 Adiponectin (ug/uL) | 6.89 (±0.53) | 6.57 (±0.40) | 0.628 |
 Oxi-LDL (U/L) | 40,718.78 (±3307.54) | 35,885.09 (±2434.90) | 0.240 |